ID   ST1A1_HUMAN             Reviewed;         295 AA.
AC   P50225; Q2NL71; Q86U58; Q92818; Q9BVU6; Q9UGG7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=Sulfotransferase 1A1;
DE            Short=ST1A1;
DE            EC=2.8.2.1;
DE   AltName: Full=Aryl sulfotransferase 1;
DE   AltName: Full=HAST1/HAST2;
DE   AltName: Full=Phenol sulfotransferase 1;
DE   AltName: Full=Phenol-sulfating phenol sulfotransferase 1;
DE            Short=P-PST 1;
DE   AltName: Full=ST1A3;
DE   AltName: Full=Thermostable phenol sulfotransferase;
DE            Short=Ts-PST;
GN   Name=SULT1A1; Synonyms=STP, STP1; ORFNames=OK/SW-cl.88;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RC   TISSUE=Brain;
RX   PubMed=8363592; DOI=10.1006/bbrc.1993.2018;
RA   Zhu X., Veronese M.E., Bernard C.C., Sansom L.N., McManus M.E.;
RT   "Identification of two human brain aryl sulfotransferase cDNAs.";
RL   Biochem. Biophys. Res. Commun. 195:120-127(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RC   TISSUE=Liver;
RX   PubMed=8484775; DOI=10.1006/bbrc.1993.1467;
RA   Zhu X., Veronese M.E., Sansom L.N., McManus M.E.;
RT   "Molecular characterisation of a human aryl sulfotransferase cDNA.";
RL   Biochem. Biophys. Res. Commun. 192:671-676(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, AND
RP   VARIANTS MET-223 AND LYS-282.
RC   TISSUE=Liver;
RX   PubMed=8423770;
RA   Wilborn T.W., Comer K.A., Dooley T.P., Reardon I.M., Heinrikson R.L.,
RA   Falany C.N.;
RT   "Sequence analysis and expression of the cDNA for the phenol-sulfating
RT   form of human liver phenol sulfotransferase.";
RL   Mol. Pharmacol. 43:70-77(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RX   PubMed=8033246; DOI=10.1016/0009-2797(94)90057-4;
RA   Yamazoe Y., Nagata K., Ozawa S., Kato R.;
RT   "Structural similarity and diversity of sulfotransferases.";
RL   Chem. Biol. Interact. 92:107-117(1994).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RC   TISSUE=Hippocampus;
RX   PubMed=7864863; DOI=10.1006/bbrc.1995.1244;
RA   Hwang S.-R., Kohn A.B., Hook V.Y.H.;
RT   "Molecular cloning of an isoform of phenol sulfotransferase from human
RT   brain hippocampus.";
RL   Biochem. Biophys. Res. Commun. 207:701-707(1995).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RC   TISSUE=Blood;
RX   PubMed=7695643; DOI=10.1006/bbrc.1995.1414;
RA   Jones A.L., Hagen M., Coughtrie M.W.H., Roberts R.C., Glatt H.;
RT   "Human platelet phenolsulfotransferases: cDNA cloning, stable
RT   expression in V79 cells and identification of a novel allelic variant
RT   of the phenol-sulfating form.";
RL   Biochem. Biophys. Res. Commun. 208:855-862(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RC   TISSUE=Liver;
RX   PubMed=7581483;
RA   Ozawa S., Nagata K., Shimada M., Ueda M., Tsuzuki T., Yamazoe Y.,
RA   Kato R.;
RT   "Primary structures and properties of two related forms of aryl
RT   sulfotransferases in human liver.";
RL   Pharmacogenetics 5:S135-S140(1995).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT MET-223.
RX   PubMed=8912648; DOI=10.1006/bbrc.1996.1628;
RA   Dooley T.P., Huang Z.;
RT   "Genomic organization and DNA sequences of two human phenol
RT   sulfotransferase genes (STP1 and STP2) on the short arm of chromosome
RT   16.";
RL   Biochem. Biophys. Res. Commun. 228:134-140(1996).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS MET-223
RP   AND LYS-282.
RX   PubMed=8924211; DOI=10.1089/dna.1996.15.367;
RA   Bernier F., Soucy P., Luu-The V.;
RT   "Human phenol sulfotransferase gene contains two alternative
RT   promoters: structure and expression of the gene.";
RL   DNA Cell Biol. 15:367-375(1996).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-223.
RC   TISSUE=Liver;
RX   PubMed=9855620;
RA   Dajani R., Hood A.M., Coughtrie M.W.;
RT   "A single amino acid, Glu146, governs the substrate specificity of a
RT   human dopamine sulfotransferase, SULT1A3.";
RL   Mol. Pharmacol. 54:942-948(1998).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANT MET-223.
RA   Raftogianis R.B., Her C., Weinshilboum R.M.;
RL   Submitted (MAR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS HIS-213 AND
RP   MET-223.
RC   TISSUE=Colon adenocarcinoma;
RA   Shichijo S., Itoh K.;
RT   "Identification of immuno-peptidmics that are recognized by tumor-
RT   reactive CTL generated from TIL of colon cancer patients.";
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   HIS-213.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   MET-223.
RC   TISSUE=Colon, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-107 (ISOFORM 1).
RX   PubMed=8288252; DOI=10.1006/geno.1993.1494;
RA   Dooley T.P., Obermoeller R.D., Leiter E.H., Chapman H.D., Falany C.N.,
RA   Deng Z., Siciliano M.J.;
RT   "Mapping of the phenol sulfotransferase gene (STP) to human chromosome
RT   16p12.1-p11.2 and to mouse chromosome 7.";
RL   Genomics 18:440-443(1993).
RN   [18]
RP   CHARACTERIZATION.
RX   PubMed=8093002; DOI=10.1042/bj3020497;
RA   Veronese M.E., Burgess W., Zhu X., McManus M.E.;
RT   "Functional characterization of two human sulphotransferase cDNAs that
RT   encode monoamine- and phenol-sulphating forms of phenol
RT   sulphotransferase: substrate kinetics, thermal-stability and
RT   inhibitor-sensitivity studies.";
RL   Biochem. J. 302:497-502(1994).
RN   [19]
RP   MUTAGENESIS OF CYS-70.
RX   PubMed=8033270; DOI=10.1016/0009-2797(94)90053-1;
RA   Falany C.N., Zhuang W., Falany J.L.;
RT   "Characterization of expressed human phenol-sulfating phenol
RT   sulfotransferase: effect of mutating cys70 on activity and
RT   thermostability.";
RL   Chem. Biol. Interact. 92:57-66(1994).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE (PAP) AND P-NITROPHENOL, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RX   PubMed=12471039; DOI=10.1074/jbc.M207246200;
RA   Gamage N.U., Duggleby R.G., Barnett A.C., Tresillian M., Latham C.F.,
RA   Liyou N.E., McManus M.E., Martin J.L.;
RT   "Structure of a human carcinogen-converting enzyme, SULT1A1.
RT   Structural and kinetic implications of substrate inhibition.";
RL   J. Biol. Chem. 278:7655-7662(2003).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE AND ESTRADIOL, CATALYTIC ACTIVITY, AND
RP   FUNCTION.
RX   PubMed=16221673; DOI=10.1074/jbc.M508289200;
RA   Gamage N.U., Tsvetanov S., Duggleby R.G., McManus M.E., Martin J.L.;
RT   "The structure of human SULT1A1 crystallized with estradiol. An
RT   insight into active site plasticity and substrate inhibition with
RT   multi-ring substrates.";
RL   J. Biol. Chem. 280:41482-41486(2005).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE.
RX   PubMed=20417180; DOI=10.1016/j.bbrc.2010.04.109;
RA   Lu J., Li H., Zhang J., Li M., Liu M.Y., An X., Liu M.C., Chang W.;
RT   "Crystal structures of SULT1A2 and SULT1A1 *3: insights into the
RT   substrate inhibition and the role of Tyr149 in SULT1A2.";
RL   Biochem. Biophys. Res. Commun. 396:429-434(2010).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) IN COMPLEXES WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE AND P-NITROPHENOL, AND CATALYTIC ACTIVITY.
RX   PubMed=21723874; DOI=10.1016/j.jmb.2011.06.037;
RA   Alcolombri U., Elias M., Tawfik D.S.;
RT   "Directed evolution of sulfotransferases and paraoxonases by ancestral
RT   libraries.";
RL   J. Mol. Biol. 411:837-853(2011).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEXES WITH
RP   ADENOSINE-3'-5'-DIPHOSPHATE AND P-NITROPHENOL, AND CATALYTIC ACTIVITY.
RX   PubMed=22069470; DOI=10.1371/journal.pone.0026794;
RA   Berger I., Guttman C., Amar D., Zarivach R., Aharoni A.;
RT   "The molecular basis for the broad substrate specificity of human
RT   sulfotransferase 1A1.";
RL   PLoS ONE 6:E26794-E26794(2011).
RN   [27]
RP   VARIANTS GLN-37; HIS-213 AND MET-223.
RX   PubMed=9345314; DOI=10.1006/bbrc.1997.7466;
RA   Raftogianis R.B., Wood T.C., Otterness D.M., Van Loon J.A.,
RA   Weinshilboum R.M.;
RT   "Phenol sulfotransferase pharmacogenetics in humans: association of
RT   common SULT1A1 alleles with TS PST phenotype.";
RL   Biochem. Biophys. Res. Commun. 239:298-304(1997).
RN   [28]
RP   VARIANT HIS-213.
RX   PubMed=10762004; DOI=10.1097/00008571-200003000-00008;
RA   Engelke C.E., Meinl W., Boeing H., Glatt H.;
RT   "Association between functional genetic polymorphisms of human
RT   sulfotransferases 1A1 and 1A2.";
RL   Pharmacogenetics 10:163-169(2000).
RN   [29]
RP   VARIANT [LARGE SCALE ANALYSIS] MET-223, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl
CC       sulfate (PAPS) as sulfonate donor to catalyze the sulfate
CC       conjugation of catecholamines, phenolic drugs and
CC       neurotransmitters. Has also estrogen sulfotransferase activity.
CC       responsible for the sulfonation and activation of minoxidil. Is
CC       Mediates the metabolic activation of carcinogenic N-
CC       hydroxyarylamines to DNA binding products and could so participate
CC       as modulating factor of cancer risk. {ECO:0000269|PubMed:12471039,
CC       ECO:0000269|PubMed:16221673}.
CC   -!- CATALYTIC ACTIVITY: 3'-phosphoadenylyl sulfate + a phenol =
CC       adenosine 3',5'-bisphosphate + an aryl sulfate.
CC       {ECO:0000269|PubMed:12471039, ECO:0000269|PubMed:16221673,
CC       ECO:0000269|PubMed:21723874, ECO:0000269|PubMed:22069470}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:12471039,
CC       ECO:0000269|PubMed:16221673, ECO:0000269|PubMed:20417180}.
CC   -!- INTERACTION:
CC       O00204:SULT2B1; NbExp=6; IntAct=EBI-2814403, EBI-749441;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50225-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50225-2; Sequence=VSP_040101;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Liver, lung, adrenal, brain, platelets and
CC       skin.
CC   -!- SIMILARITY: Belongs to the sulfotransferase 1 family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U09031; AAA18613.1; -; mRNA.
DR   EMBL; L19955; AAA02935.1; -; mRNA.
DR   EMBL; L10819; AAA35562.1; -; mRNA.
DR   EMBL; L19999; AAA99892.1; -; mRNA.
DR   EMBL; U26309; AAA67895.1; -; mRNA.
DR   EMBL; X84654; CAA59147.1; -; mRNA.
DR   EMBL; X78283; CAA55089.1; -; mRNA.
DR   EMBL; U71086; AAB09597.1; -; Genomic_DNA.
DR   EMBL; U54701; AAC50480.1; -; Genomic_DNA.
DR   EMBL; AJ007418; CAA07495.1; -; mRNA.
DR   EMBL; U52852; AAC51816.1; -; Genomic_DNA.
DR   EMBL; AB062428; BAB93491.1; -; mRNA.
DR   EMBL; BT007324; AAP35988.1; -; mRNA.
DR   EMBL; CR608214; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC020765; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000923; AAH00923.1; -; mRNA.
DR   EMBL; BC110887; AAI10888.1; -; mRNA.
DR   EMBL; L15346; AAA60595.1; -; Genomic_DNA.
DR   CCDS; CCDS10637.1; -. [P50225-2]
DR   CCDS; CCDS32420.1; -. [P50225-1]
DR   PIR; I57945; I57945.
DR   PIR; JC2523; JC2523.
DR   PIR; JC5248; JC5248.
DR   PIR; S52399; S52399.
DR   PIR; S52794; S52794.
DR   RefSeq; NP_001046.2; NM_001055.3. [P50225-1]
DR   RefSeq; NP_803565.1; NM_177529.2. [P50225-1]
DR   RefSeq; NP_803566.1; NM_177530.2. [P50225-1]
DR   RefSeq; NP_803878.1; NM_177534.2. [P50225-1]
DR   RefSeq; NP_803880.1; NM_177536.3. [P50225-2]
DR   RefSeq; XP_016879095.1; XM_017023606.1. [P50225-1]
DR   RefSeq; XP_016879100.1; XM_017023611.1. [P50225-1]
DR   RefSeq; XP_016879101.1; XM_017023612.1. [P50225-1]
DR   RefSeq; XP_016879102.1; XM_017023613.1. [P50225-1]
DR   UniGene; Hs.567342; -.
DR   UniGene; Hs.736805; -.
DR   PDB; 1LS6; X-ray; 1.90 A; A=1-295.
DR   PDB; 1Z28; X-ray; 2.30 A; A=1-295.
DR   PDB; 2D06; X-ray; 2.30 A; A/B=1-295.
DR   PDB; 3QVU; X-ray; 2.50 A; A/B=1-295.
DR   PDB; 3QVV; X-ray; 2.35 A; A/B=1-295.
DR   PDB; 3U3J; X-ray; 2.70 A; A/B=1-294.
DR   PDB; 3U3K; X-ray; 2.36 A; A/B=1-295.
DR   PDB; 3U3M; X-ray; 2.30 A; A=1-295.
DR   PDB; 3U3O; X-ray; 2.00 A; A=1-295.
DR   PDB; 3U3R; X-ray; 2.36 A; A=1-295.
DR   PDB; 4GRA; X-ray; 2.56 A; A/B=1-295.
DR   PDBsum; 1LS6; -.
DR   PDBsum; 1Z28; -.
DR   PDBsum; 2D06; -.
DR   PDBsum; 3QVU; -.
DR   PDBsum; 3QVV; -.
DR   PDBsum; 3U3J; -.
DR   PDBsum; 3U3K; -.
DR   PDBsum; 3U3M; -.
DR   PDBsum; 3U3O; -.
DR   PDBsum; 3U3R; -.
DR   PDBsum; 4GRA; -.
DR   ProteinModelPortal; P50225; -.
DR   SMR; P50225; -.
DR   BioGrid; 112686; 43.
DR   IntAct; P50225; 5.
DR   STRING; 9606.ENSP00000321988; -.
DR   BindingDB; P50225; -.
DR   ChEMBL; CHEMBL1743291; -.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB01812; Adenosine-3'-5'-Diphosphate.
DR   DrugBank; DB04417; P-Nitrophenol.
DR   DrugBank; DB00675; Tamoxifen.
DR   iPTMnet; P50225; -.
DR   PhosphoSitePlus; P50225; -.
DR   BioMuta; SULT1A1; -.
DR   DMDM; 313104286; -.
DR   OGP; P50225; -.
DR   EPD; P50225; -.
DR   MaxQB; P50225; -.
DR   PaxDb; P50225; -.
DR   PeptideAtlas; P50225; -.
DR   PRIDE; P50225; -.
DR   DNASU; 6817; -.
DR   Ensembl; ENST00000314752; ENSP00000321988; ENSG00000196502. [P50225-1]
DR   Ensembl; ENST00000350842; ENSP00000329399; ENSG00000196502. [P50225-2]
DR   Ensembl; ENST00000395607; ENSP00000378971; ENSG00000196502. [P50225-1]
DR   Ensembl; ENST00000395609; ENSP00000378972; ENSG00000196502. [P50225-1]
DR   Ensembl; ENST00000569554; ENSP00000457912; ENSG00000196502. [P50225-1]
DR   GeneID; 6817; -.
DR   KEGG; hsa:6817; -.
DR   UCSC; uc002dqi.4; human. [P50225-1]
DR   CTD; 6817; -.
DR   DisGeNET; 6817; -.
DR   GeneCards; SULT1A1; -.
DR   H-InvDB; HIX0017846; -.
DR   HGNC; HGNC:11453; SULT1A1.
DR   HPA; HPA049500; -.
DR   HPA; HPA051051; -.
DR   MIM; 171150; gene.
DR   neXtProt; NX_P50225; -.
DR   OpenTargets; ENSG00000196502; -.
DR   PharmGKB; PA343; -.
DR   eggNOG; KOG1584; Eukaryota.
DR   eggNOG; ENOG4111H56; LUCA.
DR   GeneTree; ENSGT00760000118932; -.
DR   HOGENOM; HOG000037209; -.
DR   HOVERGEN; HBG001195; -.
DR   InParanoid; P50225; -.
DR   KO; K01014; -.
DR   OMA; ISAPPKC; -.
DR   OrthoDB; EOG091G0D5F; -.
DR   PhylomeDB; P50225; -.
DR   TreeFam; TF321745; -.
DR   BioCyc; MetaCyc:HS09898-MONOMER; -.
DR   BRENDA; 2.8.2.1; 2681.
DR   Reactome; R-HSA-156584; Cytosolic sulfonation of small molecules.
DR   SABIO-RK; P50225; -.
DR   EvolutionaryTrace; P50225; -.
DR   GeneWiki; SULT1A1; -.
DR   GenomeRNAi; 6817; -.
DR   PRO; PR:P50225; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000196502; -.
DR   CleanEx; HS_SULT1A1; -.
DR   ExpressionAtlas; P50225; baseline and differential.
DR   Genevisible; P50225; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0004062; F:aryl sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0047894; F:flavonol 3-sulfotransferase activity; IDA:BHF-UCL.
DR   GO; GO:0050294; F:steroid sulfotransferase activity; IDA:UniProtKB.
DR   GO; GO:0008146; F:sulfotransferase activity; IDA:MGI.
DR   GO; GO:0050427; P:3'-phosphoadenosine 5'-phosphosulfate metabolic process; IDA:CAFA.
DR   GO; GO:0009308; P:amine metabolic process; TAS:ProtInc.
DR   GO; GO:0006584; P:catecholamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0008210; P:estrogen metabolic process; IDA:UniProtKB.
DR   GO; GO:0006068; P:ethanol catabolic process; IDA:CAFA.
DR   GO; GO:0009812; P:flavonoid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0051923; P:sulfation; IDA:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; IDA:UniProtKB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000863; Sulfotransferase_dom.
DR   Pfam; PF00685; Sulfotransfer_1; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Catecholamine metabolism;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Lipid metabolism; Phosphoprotein; Polymorphism; Reference proteome;
KW   Steroid metabolism; Transferase.
FT   CHAIN         1    295       Sulfotransferase 1A1.
FT                                /FTId=PRO_0000085127.
FT   NP_BIND      48     53       PAPS.
FT   NP_BIND     227    232       PAPS.
FT   NP_BIND     255    259       PAPS.
FT   REGION      106    108       Substrate binding.
FT   ACT_SITE    108    108       Proton acceptor. {ECO:0000250}.
FT   BINDING     130    130       PAPS.
FT   BINDING     138    138       PAPS.
FT   BINDING     193    193       PAPS.
FT   MOD_RES     138    138       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P17988}.
FT   VAR_SEQ       1    124       MELIQDTSRPPLEYVKGVPLIKYFAEALGPLQSFQARPDDL
FT                                LISTYPKSGTTWVSQILDMIYQGGDLEKCHRAPIFMRVPFL
FT                                EFKAPGIPSGMETLKDTPAPRLLKTHLPLALLPQTLLDQKV
FT                                K -> MLAKLLCDQVVGAPIAVSAFYAGMSILQGKDDIFLD
FT                                LKQKFWNTYM (in isoform 2).
FT                                {ECO:0000303|Ref.14}.
FT                                /FTId=VSP_040101.
FT   VARIANT      37     37       R -> Q (in dbSNP:rs143283780).
FT                                {ECO:0000269|PubMed:9345314}.
FT                                /FTId=VAR_009302.
FT   VARIANT     151    151       E -> D (in dbSNP:rs1042014).
FT                                /FTId=VAR_028721.
FT   VARIANT     151    151       E -> Q (in dbSNP:rs1042011).
FT                                /FTId=VAR_057339.
FT   VARIANT     213    213       R -> H (in allele SULT1A1*2; common
FT                                polymorphism; has a lower activity;
FT                                dbSNP:rs9282861).
FT                                {ECO:0000269|PubMed:10762004,
FT                                ECO:0000269|PubMed:9345314,
FT                                ECO:0000269|Ref.12, ECO:0000269|Ref.13}.
FT                                /FTId=VAR_007425.
FT   VARIANT     223    223       V -> M (in dbSNP:rs1801030).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:7581483,
FT                                ECO:0000269|PubMed:7695643,
FT                                ECO:0000269|PubMed:7864863,
FT                                ECO:0000269|PubMed:8033246,
FT                                ECO:0000269|PubMed:8363592,
FT                                ECO:0000269|PubMed:8423770,
FT                                ECO:0000269|PubMed:8484775,
FT                                ECO:0000269|PubMed:8912648,
FT                                ECO:0000269|PubMed:8924211,
FT                                ECO:0000269|PubMed:9345314,
FT                                ECO:0000269|PubMed:9855620,
FT                                ECO:0000269|Ref.11, ECO:0000269|Ref.12}.
FT                                /FTId=VAR_009303.
FT   VARIANT     235    235       N -> T (in dbSNP:rs35728980).
FT                                /FTId=VAR_014889.
FT   VARIANT     282    282       E -> K (in dbSNP:rs36043491).
FT                                {ECO:0000269|PubMed:8423770,
FT                                ECO:0000269|PubMed:8924211}.
FT                                /FTId=VAR_061886.
FT   MUTAGEN      70     70       C->S: Increased sensitivity of enzyme
FT                                activity to heat inactivation.
FT                                {ECO:0000269|PubMed:8033270}.
FT   CONFLICT     90     90       P -> L (in Ref. 3; AAA67895).
FT                                {ECO:0000305}.
FT   CONFLICT    146    146       A -> T (in Ref. 5; CAA59147).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       E -> G (in Ref. 5; CAA59147).
FT                                {ECO:0000305}.
FT   CONFLICT    243    243       V -> A (in Ref. 3; AAA67895).
FT                                {ECO:0000305}.
FT   CONFLICT    290    290       S -> T (in Ref. 3; AAA99892 and 9;
FT                                AAC50480). {ECO:0000305}.
FT   STRAND       13     15       {ECO:0000244|PDB:1LS6}.
FT   STRAND       18     20       {ECO:0000244|PDB:1LS6}.
FT   HELIX        22     31       {ECO:0000244|PDB:1LS6}.
FT   STRAND       41     46       {ECO:0000244|PDB:1LS6}.
FT   HELIX        51     62       {ECO:0000244|PDB:1LS6}.
FT   TURN         63     65       {ECO:0000244|PDB:1LS6}.
FT   HELIX        67     70       {ECO:0000244|PDB:1LS6}.
FT   HELIX        75     78       {ECO:0000244|PDB:1LS6}.
FT   STRAND       87     89       {ECO:0000244|PDB:4GRA}.
FT   HELIX        92     97       {ECO:0000244|PDB:1LS6}.
FT   STRAND      104    107       {ECO:0000244|PDB:1LS6}.
FT   TURN        111    113       {ECO:0000244|PDB:1LS6}.
FT   HELIX       116    120       {ECO:0000244|PDB:1LS6}.
FT   STRAND      124    129       {ECO:0000244|PDB:1LS6}.
FT   HELIX       132    145       {ECO:0000244|PDB:1LS6}.
FT   HELIX       155    164       {ECO:0000244|PDB:1LS6}.
FT   HELIX       172    182       {ECO:0000244|PDB:1LS6}.
FT   TURN        183    185       {ECO:0000244|PDB:1LS6}.
FT   STRAND      188    192       {ECO:0000244|PDB:1LS6}.
FT   HELIX       193    198       {ECO:0000244|PDB:1LS6}.
FT   HELIX       200    211       {ECO:0000244|PDB:1LS6}.
FT   HELIX       217    226       {ECO:0000244|PDB:1LS6}.
FT   HELIX       229    234       {ECO:0000244|PDB:1LS6}.
FT   TURN        236    238       {ECO:0000244|PDB:1LS6}.
FT   TURN        245    247       {ECO:0000244|PDB:1LS6}.
FT   TURN        250    252       {ECO:0000244|PDB:1LS6}.
FT   HELIX       263    266       {ECO:0000244|PDB:1LS6}.
FT   HELIX       270    283       {ECO:0000244|PDB:1LS6}.
FT   TURN        284    286       {ECO:0000244|PDB:1LS6}.
SQ   SEQUENCE   295 AA;  34165 MW;  7D4362A603A29176 CRC64;
     MELIQDTSRP PLEYVKGVPL IKYFAEALGP LQSFQARPDD LLISTYPKSG TTWVSQILDM
     IYQGGDLEKC HRAPIFMRVP FLEFKAPGIP SGMETLKDTP APRLLKTHLP LALLPQTLLD
     QKVKVVYVAR NAKDVAVSYY HFYHMAKVHP EPGTWDSFLE KFMVGEVSYG SWYQHVQEWW
     ELSRTHPVLY LFYEDMKENP KREIQKILEF VGRSLPEETV DFVVQHTSFK EMKKNPMTNY
     TTVPQEFMDH SISPFMRKGM AGDWKTTFTV AQNERFDADY AEKMAGCSLS FRSEL
//
